Will Martin

Chief Commercial Officer

Born in 1975. Joined IRRAS in 2018.

Mr. Martin most recently served as General Manager of the Peripheral Vascular (PV) devices business for Philips Healthcare. In this role, Mr. Martin oversaw the growth and expansion of Philips into the PV interventional space, was responsible for defining and owning the global PV business strategy, and played a key role in the acquisition of Spectranetics for more than $2B. During his tenure, the PV segment was one of the fastest growing businesses in Philips.

Prior to Philips, Mr. Martin was Vice President of Commercial Operations and Vice President of Marketing and Business Development at AtheroMed, Inc. (acquired by Volcano, Inc). In this key leadership role, he developed the global launch strategy for the Phoenix Atherectomy System and hired and led the initial US sales force during the product’s successful initial market introduction.

He served as Vice President of Sales and Marketing at Hotspur Technologies, Inc. (acquired by Teleflex), the VP of International Sales at AccessClosure, Inc. (acquired by Cardinal Health), and held other key commercial roles at Boston Scientific Corporation, Aventis Pharmaceuticals, and Corning, Inc.

Mr. Martin was a Lieutenant in the U.S. Navy. Mr. Martin received a BA from Notre Dame and an MBA from Johns Hopkins University.

Shareholding in IRRAS: 0 shares.

Holding of warrants: 230,000 warrants under the 2017/2021 warrant program, 32,500 warrants under the 2016/2025 warrant program and 12,500 warrants under the 2018/2022 warrant program.

At IRRAS, your privacy and the protection of your personal data are important to us. To ensure GDPR compliance, this website does not store or track any personal information, including Google Analytics or form submission data.
By using the website, you acknowledge and accept our policy.